SEVERE HYPERTRIGLYCERIDEMIA
Clinical trials for SEVERE HYPERTRIGLYCERIDEMIA explained in plain language.
Never miss a new study
Get alerted when new SEVERE HYPERTRIGLYCERIDEMIA trials appear
Sign up with your email to follow new studies for SEVERE HYPERTRIGLYCERIDEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise in controlling dangerously high fat levels in blood
Disease control OngoingThis study looks at the long-term safety of a drug called olezarsen for people with severe hypertriglyceridemia (very high blood fats). About 885 adults who finished a prior olezarsen study will receive the drug and be monitored for side effects and lab changes over up to 3 years…
Matched conditions: SEVERE HYPERTRIGLYCERIDEMIA
Phase: PHASE3 • Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 17, 2026 07:37 UTC
-
New shot every 3 months could tame dangerous fat levels in blood
Disease control OngoingThis study tests an injectable drug called plozasiran in 446 adults with severely high triglycerides (a type of fat in the blood). Participants receive either the drug or a placebo every three months for a year. The goal is to see if the drug safely lowers triglyceride levels and…
Matched conditions: SEVERE HYPERTRIGLYCERIDEMIA
Phase: PHASE3 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New drug plozsiran aims to tame dangerous blood fat levels
Disease control OngoingThis study tests a new drug called plozsiran in adults with severe hypertriglyceridemia, a condition where blood fat levels are dangerously high. Participants receive either the drug or a placebo every 3 months for a year. The goal is to see if plozsiran safely lowers triglycerid…
Matched conditions: SEVERE HYPERTRIGLYCERIDEMIA
Phase: PHASE3 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated May 04, 2026 16:20 UTC